Skip to main content

Table 7 Associations between microRNA-144-3p expression and clinicopathological features in lung adenocarcinoma, based on quantitative real-time PCR data

From: Down-regulation of microRNA-144-3p and its clinical value in non-small cell lung cancer: a comprehensive analysis based on microarray, miRNA-sequencing, and quantitative real-time PCR data

Clinicopathological feature

 

n

mean ± SD

p-value

Tissue

Adjacent non-cancerous tissue

101

4.693 ± 2.607

< 0.001*

LUAD

101

2.792 ± 1.308

Age (years)

< 60

41

2.8032 ± 1.31708

0.942

≥60

60

2.7838 ± 1.31347

Gender

Female

45

2.9789 ± 1.46340

0.211

Male

56

2.6413 ± 1.16082

Tumor size (cm)

≤3

53

2.9115 ± 1.41270

0.332

> 3

48

2.6594 ± 1.18327

Smoke

No

26

3.5146 ± 1.56261

0.027*

Yes

18

2.5722 ± 1.16539

Lymph node metastasis

No

45

3.0982 ± 1.3707

0.037*

Yes

56

2.5454 ± 1.21274

Vascular invasion

No

70

3.1109 ± 1.30906

< 0.001*

Yes

31

2.0710 ± 0.99515

TNM

I-II

44

2.9577 ± 1.35229

0.269

III-IV

57

2.6635 ± 1.27056

  1. SD Standard deviation, LUAD Lung adenocarcinoma
  2. *p < 0.05 was considered statistically significant